(iron overload / E-cadherin / liver / adherens junctions)
Y. FUJIKURA1,3, J. KRIJT1, C. POVÝŠIL2, Z. MĚLKOVÁ3, P. PŘIKRYL1, M. VOKURKA1, E. NEČAS1
1Institute of Pathophysiology, 2Institute of Pathology, 3Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University in Prague, Czech Republic
Pages: 95 - 102 (PDF)
Corresponding author: Yuzo Fujikura, Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University in Prague, Studničkova 7, 12800 Prague 2, Czech Republic Phone: (+420) 224 968 460; Fax: (+420) 224 968 588; e-mail: yuzofujikura@hotmail.com
(GFP / prokaryotic expression systems / cell-penetrating peptides / Pep-1 / CADY-2)
S. KADKHODAYAN1, S. M. SADAT2, S. IRANI1, F. FOTOUHI3, A. BOLHASSANI2
1Department of Biology, School of Basic Science, Science and Research Branch, Islamic Azad University, Tehran, Iran
2Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran
3Influenza Research Lab., Department of Virology, Pasteur Institute of Iran, Tehran, Iran
Pages: 103 - 109 (PDF)
Corresponding author: Azam Bolhassani, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran. Phone: (+98) 2166953311 Ext. 2240; Fax: (+98) 21 66465132; e-mail: azam.bolhassani@yahoo.com
(MS-MLPA / DNA methylation / sinonasal carcinoma / epigenetics / HPV)
M. CHMELAŘOVÁ1, I. SIRÁK2, M. MŽIK1, K. SIEGLOVÁ3, H. VOŠMIKOVÁ3, P. DUNDR4, K. NĚMEJCOVÁ4, J. MICHÁLEK5, M. VOŠMIK2, V. PALIČKA1, J. LACO3
1Institute for Clinical Biochemistry and Diagnostics, 2Department of Oncology and Radiotherapy, 3The Fingerland Department of Pathology, Charles University in Prague – Faculty of Medicine in Hradec Králové and University Hospital in Hradec Králové, Czech Republic
4Institute of Pathology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic
5Department of Clinical and Molecular Pathology, Palacký University Olomouc, Faculty of Medicine and Dentistry and University Hospital Olomouc, Czech Republic
Pages: 110 - 119 (PDF)
Corresponding author: Marcela Chmelařová, Institute for Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Sokolská 581, 500 05 Hradec Králové, Czech Republic. Phone: (+ 420) 495 833 864; e-mail: chmelarovamarcela@seznam.cz
(mesenchymal stromal cells / allogeneic / immunosuppression / GVHD)
D. LYSÁK1, L. KOUTOVÁ1, M. HOLUBOVÁ1, T. VLAS2, M. MIKLÍKOVÁ3, P. JINDRA4
1Department of Haematology and Oncology, and University Hospital in Pilsen, Pilsen, Czech Republic
2Institute of Immunology and Allergology, Charles University in Prague, Faculty of Medicine in Pilsen and University Hospital in Pilsen, Pilsen, Czech Republic
3Biomedical Centre, Charles University in Prague, Faculty of Medicine in Pilsen, Pilsen, Czech Republic
4Czech National Marrow Donor Registry (CS-2), Pilsen, Czech Republic
Pages: 120 - 130 (PDF)
Corresponding author: Daniel Lysák, Department of Haematology and Oncology, Charles University in Prague, Faculty of Medicine in Pilsen and University Hospital in Pilsen, Alej Svobody 80, 304 60 Pilsen, Czech Republic. Phone: (+420) 377 103 722; Fax: (+420) 377 104 628; e-mail: lysak@fnplzen.cz
(breast cancer / AQP4 / siRNA / E-cadherin / ERK pathway)
Y.-B. LI1, S.-R. SUN1, X.-H. HAN2
1Renmin Hospital of Wuhan University, Wuhan, China
2Inner Mongolia People’s Hospital, Hohhot, China
Pages: 131 - 137 (PDF)
Corresponding author: Sheng-Rong Sun, Renmin Hospital of Wuhan University, Wuhan 430060, China. E-mail: shukege@163.com